Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity

Scientific Reports
Zhiqiang JiangYan Sun

Abstract

Inhibition of amyloid β-protein (Aβ) aggregation is considered as a promising strategy for the prevention and treatment of Alzheimer's disease. Epigallocatechin-3-gallate (EGCG) and curcumin have been recognized as effective inhibitors of Aβ aggregation. Herein, we proposed dual-inhibitor modification of hyaluronic acid (HA) to explore the synergistic effect of the two inhibitors. EGCG-modified HA (EHA) formed dispersed hydrogel structures, while EGCG-curcumin bi-modified HA (CEHA) self-assembled into nanogels like curcumin-modified HA (CHA). Thioflavin T fluorescent assays revealed that the inhibitory effect of CEHA was 69% and 55% higher than EHA and CHA, respectively, and cytotoxicity assays showed that the viability of SH-SY5Y cells incubated with Aβ and CEHA was 28% higher than that with Aβ and the mixture of EHA and CHA. These results clearly indicate the synergism of the two inhibitors. It is considered that the difference in the hydrophobicities of the two inhibitors made the bi-modification of HA provide a favorable CEHA nanostructure that coordinated different inhibition effects of the two inhibitors. This research indicates that fabrication of dual-inhibitor nanosystem is promising for the development of potent agent...Continue Reading

References

Jun 12, 2002·The Journal of Biological Chemistry·Karie N DahlgrenMary Jo LaDu
Mar 3, 2004·Journal of Neuroscience Research·Kenjiro OnoMasahito Yamada
Jul 24, 2004·Journal of Colloid and Interface Science·Martin MalmstenGünter Siegel
Dec 14, 2004·The Journal of Biological Chemistry·Fusheng YangGregory M Cole
Jan 5, 2005·Journal of Structural Biology·M R H KrebsA M Donald
Jan 13, 2005·Acta Neuropathologica·Subhojit RoyJohn Q Trojanowski
Nov 22, 2007·European Biophysics Journal : EBJ·Geoffrey K-W KongMichael W Parker
May 31, 2008·Nature Structural & Molecular Biology·Dagmar E EhrnhoeferErich E Wanker
Sep 1, 2009·Current Alzheimer Research·R Douglas ShytleRandall S Alberte
Sep 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Leslie S WolfeYong Xiong
Apr 16, 2011·Journal of Colloid and Interface Science·S Manju, K Sreenivasan
Sep 20, 2011·Bioorganic & Medicinal Chemistry·Yuichi MasudaK Takegoshi
Dec 16, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·C Cabaleiro-LagoS Linse
Jan 13, 2012·Current Pharmaceutical Design·Susanne Aileen Funke, Dieter Willbold
Apr 25, 2013·Journal of the American Chemical Society·Fernando L PalhanoJeffery W Kelly
Jun 25, 2013·Chemical Society Reviews·Sabrina NoëlChristelle Hureau
Feb 25, 2014·Trends in Pharmacological Sciences·Paolo ArosioTuomas P J Knowles
Aug 2, 2014·Langmuir : the ACS Journal of Surfaces and Colloids·Baolong XieYan Sun
Dec 24, 2014·Acta Neuropathologica·Dietmar Rudolf ThalMarcus Fändrich
May 28, 2016·Scientific Reports·Parvez AlamRizwan Hasan Khan

❮ Previous
Next ❯

Citations

Jul 28, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Nicola MicaleMariateresa Cristani
Aug 20, 2019·Advanced Drug Delivery Reviews·Alberto Passi, Davide Vigetti
May 31, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Barnabas Wilson, Kannoth Mukundan Geetha
Oct 1, 2020·Scientific Reports·Valentina GrecoEnrico Rizzarelli
Jun 12, 2021·Frontiers in Bioengineering and Biotechnology·Amanda LiWeiwei He
Sep 12, 2018·Chemical Reviews·Nikos K KaramanosRenato V Iozzo

❮ Previous
Next ❯

Methods Mentioned

BETA
infrared spectroscopy
dynamic light scattering
transmission electron microscopy
atomic force microscopy
AFM
nuclear magnetic resonance

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.